Gossamer Bio (GOSS) Accumulated Expenses (2022 - 2025)
Historic Accumulated Expenses for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $19.3 million.
- Gossamer Bio's Accumulated Expenses rose 1072.15% to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.3 million, marking a year-over-year increase of 1072.15%. This contributed to the annual value of $15.2 million for FY2024, which is 4308.1% down from last year.
- As of Q3 2025, Gossamer Bio's Accumulated Expenses stood at $19.3 million, which was up 1072.15% from $15.6 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Accumulated Expenses registered a high of $31.5 million during Q3 2022, and its lowest value of $14.3 million during Q2 2023.
- Over the past 4 years, Gossamer Bio's median Accumulated Expenses value was $17.0 million (recorded in 2022), while the average stood at $18.8 million.
- Examining YoY changes over the last 5 years, Gossamer Bio's Accumulated Expenses showed a top increase of 2994.35% in 2023 and a maximum decrease of 4563.48% in 2023.
- Gossamer Bio's Accumulated Expenses (Quarter) stood at $20.5 million in 2022, then increased by 29.94% to $26.7 million in 2023, then crashed by 43.08% to $15.2 million in 2024, then increased by 27.03% to $19.3 million in 2025.
- Its last three reported values are $19.3 million in Q3 2025, $15.6 million for Q2 2025, and $14.8 million during Q1 2025.